이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Cardinal Health 관리
관리 기준 확인 2/4
Cardinal Health's CEO는 Jason Hollar, Sep2022 에 임명되었습니다 의 임기는 1.75 년입니다. 총 연간 보상은 $ 18.78M, 6.6% 로 구성됩니다. 6.6% 급여 및 93.4% 보너스(회사 주식 및 옵션 포함). 는 $ 4.68M 가치에 해당하는 회사 주식의 0.018% 직접 소유합니다. 4.68M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 2.8 년입니다.
주요 정보
Jason Hollar
최고 경영자
US$25.7m
총 보상
| CEO 급여 비율 | 5.6% |
| CEO 임기 | 2yrs |
| CEO 소유권 | 0.008% |
| 경영진 평균 재임 기간 | 2yrs |
| 이사회 평균 재임 기간 | 3yrs |
최근 관리 업데이트
Recent updates
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056
Sep 24
Here's Why We Think Cardinal Health (NYSE:CAH) Is Well Worth Watching
Sep 17Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Aug 19Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | US$26m | US$1m | US$852m |
| Mar 31 2024 | n/a | n/a | US$552m |
| Dec 31 2023 | n/a | n/a | US$639m |
| Sep 30 2023 | n/a | n/a | US$156m |
| Jun 30 2023 | US$19m | US$1m | US$330m |
| Mar 31 2023 | n/a | n/a | US$463m |
| Dec 31 2022 | n/a | n/a | -US$1b |
| Sep 30 2022 | n/a | n/a | -US$1b |
| Jun 30 2022 | US$4m | US$729k | -US$938m |
| Mar 31 2022 | n/a | n/a | -US$955m |
| Dec 31 2021 | n/a | n/a | US$555m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | US$4m | US$700k | US$611m |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | n/a | n/a | US$1b |
| Sep 30 2020 | n/a | n/a | US$973m |
| Jun 30 2020 | US$4m | US$124k | -US$4b |
보상 대 시장: Jason 의 총 보상 ($USD 18.78M )은 US 시장( $USD 13.50M ).
보상과 수익: Jason 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Jason Hollar (51 yo)
2yrs
테뉴어
US$25,650,709
보상
Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Director | 2yrs | US$25.65m | 0.0075% $ 2.0m | |
| Chief Financial Officer | 1.6yrs | US$6.84m | 0.0013% $ 334.7k | |
| Chief Legal & Compliance Officer | 5.5yrs | US$4.66m | 0.011% $ 2.9m | |
| Chief Executive Officer of Medical Segment | 5.1yrs | US$7.34m | 0% $ 0 | |
| Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 2yrs | US$5.09m | 0.0083% $ 2.2m | |
| Senior VP & Chief Accounting Officer | 2yrs | 데이터 없음 | 0.0051% $ 1.3m | |
| Executive VP | 2.1yrs | 데이터 없음 | 0.0080% $ 2.1m | |
| Vice President of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Chief Human Resources Officer | 5.9yrs | 데이터 없음 | 0.011% $ 3.0m | |
| Executive Vice President of Biopharma Solutions & Strategic Sourcing | no data | 데이터 없음 | 데이터 없음 | |
| Senior Vice President | 1.6yrs | US$1.26m | 0.0020% $ 541.9k | |
| President of Global Products & Supply Chain | 3.5yrs | 데이터 없음 | 데이터 없음 |
2.0yrs
평균 재임 기간
53yo
평균 연령
경험이 풍부한 관리: CAH 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Director | 2.1yrs | US$25.65m | 0.0075% $ 2.0m | |
| Independent Non-Executive Chairman | 17.1yrs | US$570.10k | 0% $ 0 | |
| Independent Director | 2yrs | US$318.09k | 0% $ 0 | |
| Independent Director | 11yrs | US$338.09k | 0.0045% $ 1.2m | |
| Independent Director | 4.2yrs | US$320.09k | 0% $ 0 | |
| Independent Director | 4yrs | US$338.09k | 0.0017% $ 446.3k | |
| Independent Director | 9yrs | US$330.61k | 0% $ 0 | |
| Independent Director | 6.6yrs | US$345.09k | 0% $ 0 | |
| Independent Director | 2yrs | US$320.09k | 0% $ 0 | |
| Independent Director | 2yrs | US$318.09k | 0.0011% $ 305.5k | |
| Independent Director | less than a year | US$182.66k | 0% $ 0 | |
| Independent Director | 2yrs | US$318.09k | 0.0014% $ 363.9k |
3.0yrs
평균 재임 기간
61yo
평균 연령
경험이 풍부한 이사회: CAH 의 이사회는 경험(평균 재직 기간 3 년)으로 간주됩니다.